Senti Biosciences, Inc. - SNTI

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$5.266M
QoQ value delta ($000)
-$566K (-9.71%)
Implied price effect (QoQ)
-19.59%
Shares
Total shares
6,304,641
QoQ shares delta
+690,276 (+12.29%)
Total shares held by funds (by quarter)

Market chart (SNTI)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 16 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
NEA Management Company, LLC 3,065 3,775,615 0.17%
Nantahala Capital Management, LLC 721 888,000 0.03%
VANGUARD GROUP INC 653 628,697 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 436 537,504 0.0%
GEODE CAPITAL MANAGEMENT, LLC 168 207,043 0.0%
VANGUARD FIDUCIARY TRUST CO 74 91,193 0.0%
MSOP GP, L.L.C. 37 35,737 0.01%
Menlo Ventures Management, L.P. 29 35,737 0.01%
BlackRock, Inc. 20 25,074 0.0%
XTX Topco Ltd 14 17,277 0.0%
NORTHERN TRUST CORP 13 16,778 0.0%
HRT FINANCIAL LP 12 14,844 0.0%
NewEdge Advisors, LLC 9 12,000 0.0%
STATE STREET CORP 8 10,010 0.0%
UBS Group AG 7 8,637 0.0%
MORGAN STANLEY 0 160 0.0%
SBI Securities Co., Ltd. 0 334 0.0%
Caitong International Asset Management Co., Ltd 0 1 0.0%